OptimizeRx (OPRX) Share-based Compensation (2010 - 2026)

OptimizeRx (OPRX) has 16 years of Share-based Compensation data on file, last reported at $17000.0 in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 80.46% year-over-year to $17000.0; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (down 4.24% YoY), and the FY2025 full-year result was $7.0 million, down 39.29% from the prior year.
• Share-based Compensation slipped to $17000.0 in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $13.2 million in Q4 2023 to a low of -$687459.0 in Q4 2022.
• A 5-year average of $2.7 million and a median of $2.0 million in 2025 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation slumped 121.96% in 2022 and surged 2016.62% in 2023, its largest moves.
• Tracing OPRX's Share-based Compensation over 5 years: stood at -$687459.0 in 2022, then surged by 2016.62% to $13.2 million in 2023, then plunged by 77.71% to $2.9 million in 2024, then tumbled by 33.27% to $2.0 million in 2025, then slumped by 99.13% to $17000.0 in 2026.
• Business Quant data shows OPRX's Share-based Compensation at $17000.0 in Q1 2026, $2.0 million in Q4 2025, and $4.9 million in Q3 2025.